Augmedix, Inc. (AUGX) Research
Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.
Market snapshot
- Symbol
- AUGX
- Price
- $2.35
- Day change
- -0.21%
- Market cap
- $115.9M
- P/E ratio
- -5.38x
- 52-week range
- 0.73-6.25
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Analyst price target
- $2.67
Peer companies
Recent insider activity
- Redmile Group, LLC — D-Return (6218238 shares) on 2024-10-02
- Redmile Group, LLC — D-Return (3125195 shares) on 2024-10-02
- Redmile Group, LLC — D-Return (1093799 shares) on 2024-10-02
- Faulkner Robert C. — D-Return (41461 shares) on 2024-10-02
- FEBBO WILLIAM J — D-Return (50000 shares) on 2024-10-02
Open Augmedix, Inc. (AUGX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.